Publication | Closed Access

Double-blind randomized study of prophylactic trimethoprim/sulfamethoxazole in granulocytopenic patients with hematologic malignancies

Hematological MalignancyOncologyHealth SciencesMalignant Blood DisorderHematologyHematologic MalignanciesPathologyProphylactic Trimethoprim/sulfamethoxazolePharmacotherapyMedicineRadiation OncologyCancer ResearchGranulocytopenic Patients